Nursing and Health Professions
General Practice
57%
Community Pharmacist
56%
Primary Medical Care
55%
Medicines Management
52%
Disease
50%
Pharmacy Technician
50%
Drug Substitution
50%
Cobicistat
50%
Cost Control
50%
PrEP
50%
Human Immunodeficiency Virus
50%
Clinical Pharmacy
50%
Efavirenz Plus Emtricitabine Plus Tenofovir Disoproxil
33%
Emtricitabine Plus Tenofovir Disoproxil
33%
Efavirenz
33%
Patient Referral
23%
Likert Scale
20%
Pharmaceutical Care
16%
Hospital
16%
Side Effect
16%
Blood Safety
16%
Lamivudine
16%
Atazanavir
16%
Cobicistat Plus Darunavir
16%
Abacavir Plus Lamivudine
16%
Darunavir
16%
Diarrhea
16%
Pharmacy
13%
Mid-Level Practitioner
12%
Accreditation
9%
Clinical Pharmacist
8%
Patient Satisfaction
8%
Community Program
6%
Pandemic
6%
Clinical Practice
6%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Pharmacology
50%
Population Study
50%
Pharmaceutical Care
50%
Cobicistat
50%
Pandemic
50%
Fenclonine
50%
Community Pharmacy
50%
Emtricitabine Plus Tenofovir Disoproxil
33%
Efavirenz Plus Emtricitabine Plus Tenofovir Disoproxil
33%
Efavirenz
33%
Syphilis
16%
Cobicistat Plus Darunavir
16%
Abacavir Plus Lamivudine
16%
Darunavir
16%
Atazanavir
16%
Lamivudine
16%
Diarrhea
16%
Side Effect
16%
Element
5%
Medicine and Dentistry
Human Immunodeficiency Virus
57%
Drug Substitution
50%
Pre-Exposure Prophylaxis
50%
Health Care Cost
50%
COVID-19
50%
Cobicistat
30%
Emtricitabine Plus Tenofovir Disoproxil
20%
Efavirenz
20%
Efavirenz Plus Emtricitabine Plus Tenofovir Disoproxil
20%
Side Effect
10%
Diarrhea
10%
Blood Safety
10%
Lamivudine
10%
Cobicistat Plus Darunavir
10%
Abacavir/Lamivudine
10%
Atazanavir
10%
Darunavir
10%
Acute Renal Failure
10%
Consultation
7%
Awareness
7%
